COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

As Omicron variant spreads, American Heart Association highlights continued support of COVID-19 vaccination

The organization also urged all eligible adults to seek out a booster shot.

Thumbnail

Most young people with vaccine-related myocarditis recover quickly

Symptoms—including chest pain, fever and shortness of breath—tend to begin within two days. Most hospitalizations last two to three days.

Thumbnail

Radiology research activities down markedly during pandemic, RSNA COVID-19 task force says

The data can help department leaders better understand “discontinuity” in staff productivity and inform promotion considerations. 

vaccine syringe covid-19 coronavirus

2 new studies confirm the ‘very low’ risk of myocarditis after COVID-19 vaccination

“The results of these two studies are valuable for doctors, patients, and the public to reduce the fear of myocarditis as a reason for excluding young people from vaccination," one specialist said. 

Cardiologist shares story after testing positive for Omicron COVID-19 variant—says he caught it during cardiology conference

The cardiologist believes he was infected while in London. His symptoms remain mild. 

New data on the link between COVID-19 vaccines and myopericarditis

The risk of myopericarditis after vaccination appears to be different for male and female patients. 

Thumbnail

Long-haul COVID-19 associated with chronic fatigue syndrome, breathing irregularities

Researchers examined a small group of long-haul COVID-19 patients, sharing their findings in JACC: Heart Failure

Taiwan reviews myocarditis data, approves second doses of Pfizer-BioNTech COVID-19 vaccine for older children

Taiwan had temporarily suspended second doses for this age group to review cases of myocarditis and pericarditis.